Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Identify the best credit card for points and cash back. Tailor your rewards to fit your lifestyle and spending patterns.
28,655 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Icon Amsterdam says 2025 was its best year yet after a broad restructuring, and it plans a phased U.S. entry in 2026,...
Miami's Dolphins stunned the league by agreeing to a record $99.2 million exit package for a veteran player. The move...
The Nasdaq Composite slips as semiconductors lead a broad pullback, challenging confidence in AI-driven growth.
A 73-year-old couple faces a narrowing window to secure legal documents and plan for growing memory-care costs as an ...
Growing demand for aging-in-place technology is reshaping funding options for seniors. This report explains how rever...
Paris Saint-Germain is testing a global lifestyle brand built on the idea that a football club can be more than its s...
Solana’s on-chain data show real-world asset transfers surging to $8.68 billion in the last 30 days, with asset value...
Hess Midstream signals a major shift from expansion to cash returns, projecting $850-$900 million in adjusted free ca...
Bitcoin faces a crucial weekend hurdle near $64,000 as ETF inflows rebound and macro momentum shifts. A sustained bre...
A newly launched XRP ETF promises to deliver twice the daily moves of XRP, inviting traders to pursue a quick double ...
Lawmakers face a looming funding gap in Social Security, with projections of trust fund depletion by the early 2030s....